A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

A.W. Tolcher, D.I. Quinn, A. Ferrari, F. Ahmann, G. Giaccone, T. Drake, A. Keating, J.S. de Bono

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)968-9U9
JournalAnnals of Oncology
Volume23
Issue number4
DOIs
Publication statusPublished - 2012

Cite this

Tolcher, A. W., Quinn, D. I., Ferrari, A., Ahmann, F., Giaccone, G., Drake, T., ... de Bono, J. S. (2012). A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. Annals of Oncology, 23(4), 968-9U9. https://doi.org/10.1093/annonc/mdr353
Tolcher, A.W. ; Quinn, D.I. ; Ferrari, A. ; Ahmann, F. ; Giaccone, G. ; Drake, T. ; Keating, A. ; de Bono, J.S. / A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. In: Annals of Oncology. 2012 ; Vol. 23, No. 4. pp. 968-9U9.
@article{673369e3bd86402aa16e0a33b0abdb11,
title = "A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer",
author = "A.W. Tolcher and D.I. Quinn and A. Ferrari and F. Ahmann and G. Giaccone and T. Drake and A. Keating and {de Bono}, J.S.",
year = "2012",
doi = "10.1093/annonc/mdr353",
language = "Undefined/Unknown",
volume = "23",
pages = "968--9U9",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "4",

}

Tolcher, AW, Quinn, DI, Ferrari, A, Ahmann, F, Giaccone, G, Drake, T, Keating, A & de Bono, JS 2012, 'A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer' Annals of Oncology, vol. 23, no. 4, pp. 968-9U9. https://doi.org/10.1093/annonc/mdr353

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer. / Tolcher, A.W.; Quinn, D.I.; Ferrari, A.; Ahmann, F.; Giaccone, G.; Drake, T.; Keating, A.; de Bono, J.S.

In: Annals of Oncology, Vol. 23, No. 4, 2012, p. 968-9U9.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

AU - Tolcher, A.W.

AU - Quinn, D.I.

AU - Ferrari, A.

AU - Ahmann, F.

AU - Giaccone, G.

AU - Drake, T.

AU - Keating, A.

AU - de Bono, J.S.

PY - 2012

Y1 - 2012

U2 - 10.1093/annonc/mdr353

DO - 10.1093/annonc/mdr353

M3 - Article

VL - 23

SP - 968-9U9

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 4

ER -